ArticleOncoTargets and therapy2022

Response of Scalp and Skull Metastasis to Anti-PD-1 Antibody Combined with Regorafenib Treatment in a Sorafenib-Resistant Hepatocellular Carcinoma Patient and a Literature Review.

Xin Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.